Sepsis: New Insights, New Therapies, Novartis Foundation Symposium / Edition 1

Hardcover (Print)
Buy New
Buy New from BN.com
$203.52
Used and New from Other Sellers
Used and New from Other Sellers
from $72.72
Usually ships in 1-2 business days
(Save 65%)
Other sellers (Hardcover)
  • All (8) from $72.72   
  • New (5) from $80.00   
  • Used (3) from $72.72   

Overview

Sepsis: New Insights, New Therapies brings together contributions from an international group of experts in diverse fields to consider how the various pathways implicated in early and late sepsis interact, with a particular emphasis on novel concepts and potential new therapeutic approaches. Topics covered include adaptive immunity, inflammation, neuroendocrinology, bioenergetics, and metabolism.

Read More Show Less

Editorial Reviews

Doody's Review Service
Reviewer: David J. Dries, MD (University of Minnesota Medical School)
Description: This monograph originated in a symposium held on sepsis by the Novartis Foundation in London in February 2006.
Purpose: Summary papers are provided with edited and referenced discussion from symposium participants.
Audience: With contributions from world thought leaders in sepsis, this is an appropriate contribution for basic researchers and academic intensivists facing sepsis.
Features: Laboratory work with cellular and molecular biology is the focus of the presentations, with mechanisms and utility of controlled apoptosis, manipulation of signal transduction, optimal resuscitation additives, and neuroendocrine response to sepsis receiving particular emphasis. Chapters are well written reviews of the topics and include discussion sections. Each chapter contains a short reference list focused on the best papers from primary literature dating to within a year of symposium activity. Line drawings and tables are occasionally used. The table of contents lists chapters and authorship while both a contributor index and a subject index optimize access to content.
Assessment: The book retains the effective conversational style of the symposium on which it is based. Because of careful editing and reference citation, readers can easily follow the contributions of various participants. This is a worthwhile update of many of the themes raised in academic discussion on sepsis management.
Read More Show Less

Product Details

  • ISBN-13: 9780470027981
  • Publisher: Wiley
  • Publication date: 4/9/2007
  • Series: Novartis Foundation Symposia Series , #194
  • Edition number: 1
  • Pages: 302
  • Product dimensions: 6.36 (w) x 9.31 (h) x 0.79 (d)

Meet the Author

The Novartis Foundation is an international scientific andeducational charity which promotes the study and general knowledgeof science and in particular encourages international co-operationin scientific research.
Chairman: Mitchell Fink

Read More Show Less

Table of Contents

Symposim on Sepsis: new insights, new therapies, held at theNovartis Foundation, London, 14-16 February 2006.

Editors: Derek J. Cahdwick (Organizer) and Jamie Goode.

This Symposim was based on a proposal made by Mitchell Fink andMervyn Singer.

Chair’s introduction (Mitchell P. Fink).

Discussion.

Strategies to modulate cellular energetic metabolism duringsepsis (Alessandro Protti and MervynSinger).

Discussion.

Immunostimulation is a rational therapeutic strategy in sepsis(Jérôme Pugin).

Discussion.

Blockade of apoptosis as a rational therapeutic strategy for thetreatment of sepsis (Alfred Ayala, Doreen E. Wesche-Soldato,Mario Perl, Joanne L. Lomas-Neira, Ryan Swan andChun-Shiang Chung).

Discussion.

Modulating neutrophil apoptosis (John C. Marshall, ZeenatMalam and Songhui Jia).

Discussion.

HMGB1 as a potential therapeutic target(Haichao Wang, WeiLi, Richard Goldstein, Kevin J. Traceyand Andrew E.Sama).

Discussion.

Poly (ADP-ribose) polymerase activation and circulatory shock(Csaba Szabó).

Discussion.

Choosing the right substrate (Xavier Leverve, CécileBatandier and Eric Fontaine).

Discussion.

Inhibiting glycogen synthase kinase 3β in sepsis(Laura Dugo, Marika Collin, David A. Allen, Nimesh S.A.Patel, Inge Bauer, Eero M. A. Mervaala, Marjut Louhelainen, SimonJ. Foster, Muhammad M. Yaqoob and ChristophThiemermann).

Discussion.

Ethyl pyruvate: a novel treatment for sepsis (Mitchell P.Fink).

Discussion.

General discussion I.

Cytoprotective and anti-inflammatory actions of carbon monoxidein organ injury and sepsis models(Stefan W. Ryter andAugustine M. K. Choi).

Discussion.

The hypothalamic pituitary adrenal axis in sepsis (AndreaPolito, Jérôme Aboab andDjillaliAnnane).

Discussion.

Modulating the endocrine response in sepsis: insulin and bloodglucose control (Ilse Vanhorebeek, Lies Langoucheand Greet Van den Berghe).

Discussion.

The neuronal strategy for inflammation(LuisUlloaand Ping Wang).

Discussion.

Beta-blockade in burns (C. T. Pereira, M. G.Jeschke and D. N. Herndon).

Discussion.

System interactions (Mervyn Singer).

Discussion.

Protecting the permeability pore and mitochondrial biogenesis(C. A. Piantadosi, M. S. Carraway, D. W. Haden andH. B. Suliman).

Discussion.

Contributor Index.

Subject index.

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)